Showing results (191-200 of 738) with videos related to
Sort By:
Pageof 74
Drug and Alcohol Dependence|October 27, 1998
Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern CaliforniaA A Gleghorn, R Marx, E Vittinghoff, et al.Archives of Internal Medicine|July 1, 1992
CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatmentM H Katz, A B Bindman, D Keane, et al.The Journal of Experimental Medicine|June 1, 1981
Stimulation of primary in vitro IgE antibody responses in culture of human peripheral mononuclear cellsM Nonaka, B L Zuraw, C H O'Hair, et al.Proteins|September 30, 2009
Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonistsBrajesh K Rai, Gregory J Tawa, Alan H Katz, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|December 19, 2019
Concurrent urinary and bowel diversion: Surgical modification with sigmoid colon that avoids a bowel anastomosisDidi P Theva, Angela Kuhnen, Richard K Babayan, et al.Human Genetics|August 31, 1978
Gene frequency estimates for samples of Black and White twins from the Philadelphia metropolitan areaA J Pakstis, H F Polesky, S Scarr, et al.The American Journal of Physiology|February 10, 1999
Endocytosis at the apical plasma membrane of pancreatic acinar cells is regulated by tyrosine kinasesS D Freedman, M H Katz, E M Parker, et al.The Journal of Experimental Medicine|August 1, 1970
Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responsesW E Paul, D H Katz, E A Goidl, et al.The Cochrane Database of Systematic Reviews|September 14, 2012
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patientsLior H Katz, Hadar Goldvaser, Anat Gafter-Gvili, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Activation of T and B lymphocytes in vitro: presence of beta2-microblobulin determinants on allogeneic effect factorD Armerding, R T Kubo, H M Grey, et al.Pageof 74